Announcements Trials
Browse Landscape

Phase

Phase 2 40Phase NA 18Phase 3 13Phase 1 6Phase 2/3 3Phase EARLY_PHASE1 2Phase 1/2 2

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Squamous Cell Carcinoma of Head and Neck 2Breast Neoplasms 2Triple Negative Breast Neoplasms 1Successful Conversion Rate of Operation 1Sarcoma 1Pancreatic Ductal Adenocarcinoma 1Ovarian Neoplasms 1Neoplasms 1Mouth Neoplasms 1Head and Neck Neoplasms 1Desmoplastic Small Round Cell Tumor 1Breast Neoplasms, Male 1

Interventions

Letrozole 7Fluorodeoxyglucose F18 7Magnetic Resonance Spectroscopy 5Blood Specimen Collection 5pembrolizumab 4atezolizumab 4Trastuzumab 4Oncolytic Virotherapy 4Bevacizumab 4palbociclib 3Saline Solution 3Fish Oils 3Docosahexaenoic Acids 3Denosumab 3Carboplatin 3Biopsy 3pertuzumab 2olaparib 2Vitamin D 2Vinorelbine 2Taxes 2Sentinel Lymph Node Biopsy 2Radiotherapy 2Positron-Emission Tomography 2Positron Emission Tomography Computed Tomography 2Paclitaxel 2Omacor 2Neoadjuvant Therapy 2Metformin 2Lapatinib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Breast Neoplasms × Neoadjuvant Therapy × Clear all
NCT03387553 2026-05-07

HER2 Directed Dendritic Cell Vaccine During Neoadjuvant Therapy of HER2+Breast Cancer

H. Lee Moffitt Cancer Center and Research Institute

Phase EARLY_PHASE1 Completed
31 enrolled
Breast

Breast Neoplasms, Breast Neoplasms, Male

NCT05333874 2026-02-09

CIPHER Study: Pilot Study to Study the Role of ctDNA in Triple Negative and HER2 Positive Early Stage

Rutgers, The State University of New Jersey

Phase EARLY_PHASE1 Active not recruiting
34 enrolled
Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡